Literature DB >> 31870802

International consensus guidelines for surgery and the timing of intervention in chronic pancreatitis.

M A Kempeneers1, Y Issa1, U Ahmed Ali2, R D Baron3, M G Besselink1, M Büchler4, M Erkan5, C Fernandez-Del Castillo6, S Isaji7, J Izbicki8, J Kleeff9, J Laukkarinen10, A R G Sheel11, T Shimosegawa12, D C Whitcomb13, J Windsor14, Y Miao15, J Neoptolemos4, M A Boermeester16.   

Abstract

BACKGROUND/
OBJECTIVES: Chronic pancreatitis (CP) is a complex inflammatory disease with pain as the predominant symptom. Pain relief can be achieved using invasive interventions such as endoscopy and surgery. This paper is part of the international consensus guidelines on CP and presents the consensus guideline for surgery and timing of intervention in CP.
METHODS: An international working group with 15 experts on CP surgery from the major pancreas societies (IAP, APA, JPS, and EPC) evaluated 20 statements generated from evidence on 5 questions deemed to be the most clinically relevant in CP. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach was used to evaluate the level of evidence available for each statement. To determine the level of agreement, the working group voted on the 20 statements for strength of agreement, using a nine-point Likert scale in order to calculate Cronbach's alpha reliability coefficient.
RESULTS: Strong consensus was obtained for the following statements: Surgery in CP is indicated as treatment of intractable pain and local complications of adjacent organs, and in case of suspicion of malignant (cystic) lesion; Early surgery is favored over surgery in a more advanced stage of disease to achieve optimal long-term pain relief; In patients with an enlarged pancreatic head, a combined drainage and resection procedure, such as the Frey, Beger, and Berne procedure, may be the treatment of choice; Pancreaticoduodenectomy is the most suitable surgical option for patients with groove pancreatitis; The risk of pancreatic carcinoma in patients with CP is too low (2% in 10 year) to recommend active screening or prophylactic surgery; Patients with hereditary CP have such a high risk of pancreatic cancer that prophylactic resection can be considered (lifetime risk of 40-55%). Weak agreement for procedure choice in patients with dilated duct and normal size pancreatic head: both the extended lateral pancreaticojejunostomy and Frey procedure seems to provide equivalent pain control in patients.
CONCLUSIONS: This international expert consensus guideline provides evidenced-based statements concerning key aspects in surgery and timing of intervention in CP. It is meant to guide clinical practitioners and surgeons in the treatment of patients with CP.
Copyright © 2019 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Classification; Definition; Risk factors; Surgery; Treatment

Year:  2019        PMID: 31870802     DOI: 10.1016/j.pan.2019.12.005

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  14 in total

1.  Groove Pancreatitis and Gastric Outlet Obstruction.

Authors:  Manuela Monrabal Lezama; Cristian A Angeramo; Miguel E Nazar; Pablo Capitanich; Francisco Schlottmann
Journal:  J Gastrointest Surg       Date:  2021-05-05       Impact factor: 3.452

2.  Pain Management in Chronic Pancreatitis: Summary of Clinical Practice, Current Challenges and Potential Contribution of the M-ANNHEIM Classification.

Authors:  Alexander Schneider; Michael Hirth
Journal:  Drugs       Date:  2021-02-15       Impact factor: 9.546

Review 3.  Endoscopic Management of Complications in Chronic Pancreatitis.

Authors:  Ahmed Dirweesh; Guru Trikudanathan; Martin L Freeman
Journal:  Dig Dis Sci       Date:  2022-02-28       Impact factor: 3.199

4.  Frey's plus versus Frey's procedure for chronic pancreatitis: Analysis of postoperative outcomes and quality of life.

Authors:  Gunasekaran Gopalakrishnan; Raja Kalayarasan; Senthil Gnanasekaran; Biju Pottakkat
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2020-11-30

5.  Laparoscopic Beger procedure for the treatment of chronic pancreatitis: a single-centre first experience.

Authors:  He Cai; Yunqiang Cai; Xin Wang; Bing Peng
Journal:  BMC Surg       Date:  2020-04-29       Impact factor: 2.102

6.  Transpapillary tissue sampling of biliary strictures: balloon dilatation prior to forceps biopsy improves sensitivity and accuracy.

Authors:  Daniel Pörner; Dominik J Kaczmarek; Dominik Heling; Annekristin Hausen; Raphael Mohr; Robert Hüneburg; Hanno Matthaei; Tim R Glowka; Steffen Manekeller; Hans-Peter Fischer; Marieta Toma; Jacob Nattermann; Christian P Strassburg; Maria A Gonzalez-Carmona; Tobias J Weismüller
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

7.  Circulating miRNA in Patients Undergoing Total Pancreatectomy and Islet Autotransplantation.

Authors:  Srividya Vasu; Jiemin M Yang; James Hodges; Maisam A Abu-El-Haija; David B Adams; Appakalai N Balamurugan; Greg J Beilman; Srinath Chinnakotla; Darwin L Conwell; Martin L Freeman; Timothy B Gardner; Betul Hatipoglu; Varvara Kirchner; Luis F Lara; Katherine A Morgan; Jaimie D Nathan; Andrew Posselt; Timothy L Pruett; Sarah J Schwarzenberg; Vikesh K Singh; Martin Wijkstrom; Piotr Witkowski; Bashoo Naziruddin; Melena D Bellin
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

Review 8.  Painful chronic pancreatitis - new approaches for evaluation and management.

Authors:  Dhiraj Yadav; Tonya M Palermo; Anna E Phillips; Melena D Bellin; Darwin L Conwell
Journal:  Curr Opin Gastroenterol       Date:  2021-09-01       Impact factor: 2.741

9.  Disease duration before surgical resection for chronic pancreatitis impacts long-term outcome.

Authors:  Antonie Willner; Andreas Bogner; Benjamin Müssle; Christian Teske; Sebastian Hempel; Christoph Kahlert; Marius Distler; Jürgen Weitz; Thilo Welsch
Journal:  Medicine (Baltimore)       Date:  2020-10-30       Impact factor: 1.817

10.  The in situ near-total pancreatectomy (LIVOCADO procedure) for end-staged chronic pancreatitis.

Authors:  Ryan D Baron; Andrea R G Sheel; Ammad Farooq; Jörg Kleeff; Pietro Contin; Christopher M Halloran; John P Neoptolemos
Journal:  Langenbecks Arch Surg       Date:  2021-06-25       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.